BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19507571)

  • 1. [Histological malignancy grade of renal cancer: karyo- and stereometric analysis].
    Iurin AG; Koval'skiĭ GB
    Arkh Patol; 2009; 71(2):13-8. PubMed ID: 19507571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleolar grading of renal cancer. Correlation of frequency and localization of nucleoli to histologic and cytologic grading and stage of renal cell carcinomas.
    Helpap B; Knüpffer J; Essmann S
    Mod Pathol; 1990 Nov; 3(6):671-8. PubMed ID: 2263592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic value of the histological grading of cancer of the kidney].
    Vlodavskiĭ EA
    Vopr Onkol; 1988; 34(11):1359-62. PubMed ID: 3201772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Histological and cytological (nucleolar) grading of renal cell carcinoma].
    Helpap B; Knüpffer J; Essmann S
    Verh Dtsch Ges Pathol; 1989; 73():400-4. PubMed ID: 2482626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Survival in non-metastatic clear-cell renal cancer].
    Iurin AG
    Vopr Onkol; 2010; 56(1):50-4. PubMed ID: 20361615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of the presence of the worst nucleolar grade in renal cell carcinoma specimens.
    Ito K; Yoshii H; Asakuma J; Sato A; Horiguchi A; Sumitomo M; Hayakawa M; Asano T
    Jpn J Clin Oncol; 2009 Sep; 39(9):588-94. PubMed ID: 19556339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary collecting system invasion is an independent prognostic factor of organ confined renal cell carcinoma.
    Verhoest G; Avakian R; Bensalah K; Thuret R; Ficarra V; Artibani W; Tostain J; Guille F; Cindolo L; De La Taille A; Abbou CC; Salomon L; Rioux-Leclercq N; Patard JJ
    J Urol; 2009 Sep; 182(3):854-9. PubMed ID: 19616244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fuhrman grading is not appropriate for chromophobe renal cell carcinoma.
    Delahunt B; Sika-Paotonu D; Bethwaite PB; McCredie MR; Martignoni G; Eble JN; Jordan TW
    Am J Surg Pathol; 2007 Jun; 31(6):957-60. PubMed ID: 17527087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor size is a determinant of the rate of stage T1 renal cell cancer synchronous metastasis.
    Lughezzani G; Jeldres C; Isbarn H; Perrotte P; Shariat SF; Sun M; Widmer H; Arjane P; Peloquin F; Pharand D; Patard JJ; Graefen M; Montorsi F; Karakiewicz PI
    J Urol; 2009 Oct; 182(4):1287-93. PubMed ID: 19683281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal cell carcinoma: assessment of key pathologic prognostic parameters and patient characteristics in 47,909 cases using the National Cancer Data Base.
    Nese N; Paner GP; Mallin K; Ritchey J; Stewart A; Amin MB
    Ann Diagn Pathol; 2009 Feb; 13(1):1-8. PubMed ID: 19118775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifocality incidence and accompanying clinicopathological factors in renal cell carcinoma.
    Sargin SY; Ekmekcioglu O; Arpali E; Altinel M; Voyvoda B
    Urol Int; 2009; 82(3):324-9. PubMed ID: 19440022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation of serum calcium level with tumor size and stage of renal cell carcinoma].
    Bai H; Zheng SB; Wu J; Liu DZ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1435-7. PubMed ID: 16305975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical characteristics of renal cell carcinoma in female patients.
    Chen J; Shi B; Zhang D; Jiang X; Xu Z
    Int J Urol; 2009 Jun; 16(6):554-7. PubMed ID: 19456990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organ-confined clear cell renal cell carcinoma: the prognostic impact of microvascular invasion, nuclear grade and tumour size.
    Zubac DP; Bostad L; Kihl B; Eide J; Wentzel-Larsen T; Haukaas SA
    APMIS; 2008 Dec; 116(12):1027-33. PubMed ID: 19133004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival.
    Zubac DP; Bostad L; Kihl B; Seidal T; Wentzel-Larsen T; Haukaas SA
    J Urol; 2009 Nov; 182(5):2144-9. PubMed ID: 19758660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinicopathological observation on renal cell carcinoma. "The relationship between the histological and clinical findings"].
    Yoneda F; Tsujimura H; Kagawa S; Kurokawa K; Akagi G
    Hinyokika Kiyo; 1985 Sep; 31(9):1525-9. PubMed ID: 2417462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Four cases of sarcomatoid renal cell carcinoma].
    Takada T; Kinouchi T; Kinoshita T; Hatano K; Kobayashi M; Inoue H; Hara T; Yamaguchi S
    Hinyokika Kiyo; 2009 Feb; 55(2):93-7. PubMed ID: 19301614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal cell carcinoma with syncytial giant cell component.
    Lloreta J; Bielsa O; Munné A; Domínguez D; Keysers U; Gelabert A; Serrano S
    Virchows Arch; 2002 Mar; 440(3):330-3. PubMed ID: 11889606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma.
    Amin MB; MacLennan GT; Gupta R; Grignon D; Paraf F; Vieillefond A; Paner GP; Stovsky M; Young AN; Srigley JR; Cheville JC
    Am J Surg Pathol; 2009 Mar; 33(3):384-92. PubMed ID: 19011562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The degree of malignancy and histologic variants of kidney cancer: their importance in diagnosis and prognosis].
    Shlopov VG; Vlodavskiĭ EA; Tikhonova VI
    Arkh Patol; 1988; 50(10):21-7. PubMed ID: 3219083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.